GlassScriptPhysician profile
Colter Johnson
NPI 1215670013
$1,734.51
in general payments reported to CMS, 2019-2025
21 companies · $945 in 2025
The $945 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $331 · 2023: $214 · 2024: $245 · 2025: $945.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,403.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $517.46 | 2022-2025 | |
| Calyxo, INC. | $137.67 | 2025 | Cvac Aspiration System |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2024 | Airsupra |
| Janssen Biotech, INC. | $123.79 | 2025 | Carvykti, Rybrevant, Erleada |
| Procept Biorobotics Corporation | $114.84 | 2025 | |
| Merck Sharp & Dohme LLC | $110.90 | 2025 | Keytruda |
| Edwards Lifesciences Corporation | $96.61 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Pfizer INC. | $89.22 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $83.97 | 2025 | Gemtesa, Orgovyx |
| Biohaven Pharmaceutical Holding Company LTD. | $77.36 | 2022 | |
| Immunitybio, INC. | $40.63 | 2025 | |
| Laborie Medical Technologies Corp. | $35.48 | 2025 | Endosheath Technology |
| Urogen Pharma, INC. | $28.95 | 2025 | |
| Olympus America INC. | $24.63 | 2025 | Bovie, Itind System, Uretero-Reno Videoscope |
| Dendreon Pharmaceuticals LLC | $24.30 | 2025 | Provenge |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $19.84 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.62 | 2025 | |
| Ferring Pharmaceuticals INC. | $18.45 | 2025 | Adstiladrin |
| 180 Medical, INC. | $18.04 | 2025 | |
| Medtronic, INC. | $16.67 | 2025 | Interstim |
| Lilly USA, LLC | $12.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colter Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.